Continuous Glucose Monitoring Market Outlook, Scope & Overview: Industry reports indicate that the global continuous glucose monitoring (CGM) market was valued at USD 7.92 billion in 2023 and is projected to reach USD 11.10 billion by 2031, growing at a CAGR of 4.03% over the forecast period 2024-2031. Technological Advancements to Drive Growth of Global Continuous Glucose Monitoring Market The adoption of continuous glucose monitoring technologies will continue to influence global market revenues. Diabetes management is increasingly relying on CGM systems to provide real-time glucose data, improve glycemic control, and enhance patient outcomes. As a product segment, wearable CGM devices currently hold a significant share of the global CGM market. This segment is anticipated to grow at a year-over-year rate of 4.03% in 2024 over 2023 and reach USD 11.10 billion in revenues by 2031. The increasing prevalence of diabetes, coupled with advancements in sensor technologies and data analytics, is expected to drive market growth. Get a Free Sample Report: https://www.snsinsider.com/sample-request/3055 Continuous Glucose Monitoring Solutions – Market Dynamics Drivers: Continuous glucose monitoring solutions are witnessing significant growth in the global market due to their ability to provide real-time glucose measurements, reduce the frequency of fingerstick tests, and support better diabetes management. The rising prevalence of diabetes worldwide, the growing adoption of personalized medicine, and advancements in CGM technologies, such as improved accuracy and longer sensor life, are key factors driving the adoption of CGM systems. Additionally, the increasing awareness about diabetes management and the expanding patient population are further propelling market growth. Restraints: Despite the growth potential, challenges such as high costs associated with CGM systems, limited insurance coverage, and concerns about data privacy are hindering the widespread adoption of continuous glucose monitoring solutions. Moreover, the need for regular calibration and the potential for sensor inaccuracies pose additional challenges to market expansion. Continuous Glucose Monitoring Solutions – Market Outlook The proven benefits of continuous glucose monitoring solutions in enhancing diabetes management, improving patient outcomes, and reducing healthcare costs have contributed to the market's growth. CGM solutions are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in technology and the growing focus on diabetes care and prevention. Global Continuous Glucose Monitoring Market The rise in demand for continuous glucose monitoring solutions in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global CGM market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of CGM solutions, supported by increasing healthcare expenditures and rising diabetes prevalence. Key Players in the Continuous Glucose Monitoring Market Leading companies in the continuous glucose monitoring market include Dexcom, Inc., Abbott Laboratories, Medtronic plc, and Senseonics Holdings, Inc. These companies are at the forefront of developing and commercializing advanced CGM systems for various diabetes management applications, including real-time glucose monitoring and data analytics. In conclusion, the global continuous glucose monitoring market is poised for steady growth over the forecast period, driven by technological advancements, increasing diabetes prevalence, and the expanding adoption of CGM solutions in diabetes care and management. Other Trending Reports Women’s Health Therapeutics Industry Growth Clinical Trial Management System Industry Growth Wireless Brain Sensors Industry Growth Neuroendoscopy Industry Growth Assisted Reproductive Technology Market Mayur Pande |
Free forum by Nabble | Edit this page |